CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE2531.25421.85 (+20 %)
PREV CLOSE () 2109.40
OPEN PRICE () 2109.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30720
TODAY'S LOW / HIGH ()2109.40 2531.25
52 WK LOW / HIGH ()1250.95 2531.25
NSE2545.00424.1 (+20 %)
PREV CLOSE() 2120.90
OPEN PRICE () 2110.00
BID PRICE (QTY) 2545.00 (22450)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 482367
TODAY'S LOW / HIGH() 2110.00 2545.00
52 WK LOW / HIGH ()1239.3 2545
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1987

Management Info :

Bhupendra Gandhi - Chairman Rajiv Gandhi - Managing Director

Registered Office :

Address : Meda Adraj,Taluka Kadi, ,
Mehsana Dist,
Gujarat-384441

Phone : 079 – 26445106

Email : mail@hester.in

Website : www.hester.in

Registrar's Details : MUFG Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE
NEWS
08Jul Hester Biosciences informs about corr
Pursuant to applicable Regulations of the SEBI (Listing Obligations and..
19Jun Hester Biosciences informs about press
Hester Biosciences has informed that it enclosed a copy of each newspape..
18Jun Hester Biosciences informs about recor
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosur..
18Jun Hester Biosciences informs about BRSR
Hester Biosciences has informed that the Business Responsibility and Sus..
18May Hester Biosciences informs about trans
Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligation..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit263.84521
Gross Profit 348.7 696.82
Operating Profit 356.44801.07
Net Sales 937.132921.36
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27384.30 (0.96%)
M.Cap ( in Cr)
58189.73
Fredun Pharma (BSE)
 2753.70 (6.59%)
M.Cap ( in Cr)
1518.03
Astrazeneca Pharma (BSE)
 8271.35 (1.82%)
M.Cap ( in Cr)
20678.38
Acutaas Chemicals (BSE)
 3495.30 (2.99%)
M.Cap ( in Cr)
28616.41
Divi's Laboratories (BSE)
 6933.15 (1.43%)
M.Cap ( in Cr)
184053.35
Shareholding Pattern
PROMOTERS 53.73%
NON-INSTITUTION 45.89%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77616.4047.01 (0.06%)
NIFTY24211.004.10 (0.02%)
Dow Jones 52637.01149.60 (0.29%)
Nasdaq 26281.6174.72 (0.29%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI